Breakthrough RSV Vaccine for Pregnant Women: Protecting Newborns"
"π Exciting News Alert! The US just approved the first-ever RSV vaccine for pregnant women - Abrysvo by Pfizer. This groundbreaking vaccine aims to protect newborns from respiratory infections like RSV. Learn all about it in this video! π #RSVVaccine #Abrysvo #PfizerVaccine π In this video, we break down: - Introduction to Abrysvo and its FDA approval on August 21, 2023. - How Abrysvo works: A single injection between 32-36 weeks of pregnancy triggers the mom's immune system to produce protective antibodies for the baby. - The significance of RSV: Common virus causing severe complications in infants and elderly. - Impressive clinical trial results: 82% reduction in severe RSV disease risk in the first 3 months of life and 69% reduction at 6 months. - Considerations and Future Monitoring: Pfizer's response to slight variations in premature birth rates. - Conclusion and Looking Ahead: Expect CDC recommendations soon! @VidPediaEd π Stay informed about this game-change...